Business context and reporting period
BHAV Acquisition Corp, a special purpose acquisition company, reported on November 3, 2026, that it entered into a business combination agreement with Nemi Corp. and related merger entities, including BNC Motors Pvt. Ltd. The agreement contemplates Nemi becoming a publicly traded company, with BHAV and its merger subsidiaries becoming subsidiaries of Pubco. The filing does not describe Nemi’s business operations in detail.
Transaction and key financial terms
- Nemi shareholders are to receive 40,000,000 newly issued Pubco common shares, stated to represent an aggregate value of $400 million. This base share number includes shares for Nemi equity awards and securities issued upon conversion of permitted financing securities.
- Closing requires at least $30 million of Available Closing Cash. The filing does not state the expected closing cash balance, redemptions, financing proceeds, or pro forma ownership.
- Pubco’s equity incentive plan is to reserve 15% of fully diluted post-closing shares, with at least 10% available for new grants, and include an annual evergreen increase.
- Nemi’s founder and certain affiliated holders will receive high-vote Class B shares carrying 10 votes per share; other Pubco Class A shares carry one vote per share. Class B shares are convertible one-for-one into Class A shares.
The filing provides no historical or current revenue, profit, margins, cash flow, debt, or liquidity figures for Nemi or BHAV. It therefore does not permit an assessment of operating performance or changes versus a prior comparable period.
Material terms, outlook, and risks
- The transaction remains subject to BHAV shareholder approval, regulatory and antitrust approvals, an effective Form S-4/proxy statement, Nasdaq listing approval, at least $30 million of closing cash, and other conditions, including completion of specified BNC restructuring steps and Nemi holding at least 99.74% of BNC shares.
- Nemi is to use commercially reasonable efforts to deliver audited target-company financial statements for fiscal 2024 and 2025 within 30 calendar days after signing; the date may be extended for specified delays or by agreement. The parties expect to file the Form S-4 within 30 business days after delivery, subject to extension while they work on it.
- The agreement may generally be terminated if closing has not occurred by June 20, 2027, subject to extension if BHAV’s business-combination deadline is extended and other contractual terms.
- After closing, the board is to have five members: one designated by BHAV and four by Nemi shareholders, with at least three independent directors. Nemi CEO Anirudh Ravi Narayanan is expected to become Pubco CEO.
- Proposed lock-ups generally run for up to six months for specified holders and up to 24 months for the founder and an affiliate, subject to transaction and share-price-based early release provisions; the founder’s price-based release also requires quarterly revenue of at least $30 million.
- Risks identified include failure to obtain approvals or satisfy closing conditions, redemptions and transaction costs, Nasdaq listing requirements, execution and growth risks, customer adoption and product commercialization, competition and pricing pressure, supply-chain and intellectual-property risks, and political or economic instability in markets where the companies operate or plan to operate. The filing contains no quantified forecast or guidance.
Most important facts to verify
- Review the forthcoming Form S-4/proxy statement for Nemi’s audited 2024 and 2025 financials, interim results, forecasts, valuation assumptions, pro forma capitalization, and dilution from redemptions and financing securities.
- Confirm the actual Available Closing Cash, expected redemptions, financing commitments, and whether all closing conditions—including the BNC restructuring and ownership requirement—are met.
- Review the final voting and economic rights of Pubco’s share classes, equity-plan dilution, lock-up terms, and post-closing ownership and governance.
- Track shareholder and regulatory approvals, Nasdaq listing, the Form S-4 timetable, and any changes to the outside date or transaction terms.